SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (615)4/16/2002 2:30:06 PM
From: semi_infinite   Read Replies (2) of 706
 
The stock is already discounting growth rate of 25-30%. What it hasn't discounted is higher growth that the company seem to have achieved in the last 6 and the most recent seasonably weak quarter of 50%-90%. I don't see a slowing down of adoption any time soon when penetration is only 0.7% of the gp market and essentially 0% in the endo market. So, I would agree with Cardillo about the outcome (a double) but not what I think is a pessimistic assessment of growth over the next 2 years. The stock really reminds me of Photon Dynamics back in 1997-98 when very few people understood what the company technology is about.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News